http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008102118-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2e185a6ae9614f70feff5d7c2e1f708 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
filingDate | 2006-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d9b4f1bedaaa18a899fe694ba1d08e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da92dc80befd02e7c1dd09a582dad900 |
publicationDate | 2008-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2008102118-A1 |
titleOfInvention | Glipizide controlled-release composition and method of preparation |
abstract | A glipizide controlled release composition is provided comprising a drug-layer and a push-layer at a ratio of 1:0.5˜3 by weight. The drug-layer contains glipizide and 40˜99 percent by weight of the drug-layer of hydrophilic polyvinylpyrrolidone homopolymer and/or copolymer carrier. The push-layer comprises about 10 to 80 percent by weight of the push-layer of osmopolymers, about 10 to 80 percent by weight of the push-layer of water-insoluble polymers, and about 5 to 50 percent by weight of the push-layer of osmagents. The composition is used in osmotic pump tablets for controlled release of glipizide useful for administration once a day. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008210559-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8076820-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2488731-B |
priorityDate | 2006-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 191.